Wesana Health Holdings Inc
Change company Symbol lookup
Select an option...
WSNAF Wesana Health Holdings Inc
ZEUS Olympic Steel Inc
EJH E-Home Household Service Holdings Ltd
AMZN Amazon.com Inc
BGTTF Goat Industries Ltd
BRDS Bird Global Inc
GHM Graham Corp
DRMA Dermata Therapeutics Inc
VGAS Verde Clean Fuels Inc
CURV Torrid Holdings Inc
Go


Based in Canada
Company profile

Wesana Health Holdings Inc is a Canada-based life science company. The Company is engaged in development and delivery of psychedelic and naturally sourced therapies to treat traumatic brain Injury related depressive disorder, anxiety and migraines through drug development and predictive diagnostics. The Company is also engaged in care development through its therapies and patent-pending protocols, and in care delivery through activating a multidisciplinary, technology-supported clinical model. Its SANA-013 is a novel composition and method of use that provides sustained effects and benefit over time. The Company’s novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen of a micro dose of psilocybin combined with cannabidiol, significantly reduced depressive behaviors in a validated animal model.

Closing Price
$0.036
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Heavy Day)
Volume:
19,050

10-day average volume:
19,346
19,050

Broadcom Inc. Stock Outperforms Competitors Despite Losses On The Day

4:38 pm ET January 19, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Broadcom Inc. (AVGO) slid 1.93% to $563.22 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.76% to 3,898.85 and Dow Jones Industrial Average falling 0.76% to 33,044.56. This was the stock's second consecutive day of losses. Broadcom Inc. closed $82.09 below its 52-week high ($645.31), which the company reached on March 29th.

Despite its losses, the stock outperformed some of its competitors Thursday, as NVIDIA Corp. (NVDA) fell 3.52% to $167.65. Trading volume (2.3 M) remained 127,769 below its 50-day average volume of 2.4 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 19, 2023.

	

(END) Dow Jones Newswires

January 19, 2023 16:38 ET (21:38 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.